Relationship Between Inducible NOS Single-nucleotide Polymorphisms and Hypertension in Han Chinese

Overview

Journal Herz

Specialty Cardiology & Vascular Diseases

Date 2017 Jul 8

PMID 28685250

Citations 6

Authors

Z Zhai

Z Wang

L Wang

S Chen

H Ren

D Wang

Affiliations

Soon will be listed here.

Abstract

Background: Inducible nitric oxide synthase (iNOS) single-nucleotide polymorphisms have been reported to confer susceptibility to hypertension, but no consensus has been reached. The aim of this study was to investigate the association between iNOS and hypertension in a Chinese population.

Methods: This was a case-control study including 1172 hypertensive and 1172 control subjects to investigate the association between iNOS and hypertension.

Results: There were significant differences in the distribution of genotype and allele frequencies of rs2779249 and rs2297518 between hypertensive and normotensive subjects. Logistic regression analyses were performed with different genetic models (additive, dominant, recessive) adjusting for confounding risk covariates, including age, sex, body mass index, total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, smoking, drinking, and family history of hypertension. The odds ratio (OR) was 1.27 (1.12, 1.44) in the additive model, 1.31 (1.09, 1.59) in the dominant, and 1.68 (1.28, 2.19) in the recessive model of rs2779249; the OR was 1.26 (1.06, 1.50) in the additive model and 1.46 (1.13, 1.89) in the dominant model of rs2297518.

Conclusion: The current study provides evidence that iNOS is strongly associated with hypertension.

Citing Articles

Management of Hypertension in the Asia-Pacific Region: A Structured Review.

Rahman A, Magno J, Cai J, Han M, Lee H, Nair T Am J Cardiovasc Drugs. 2024; 24(2):141-170.

PMID: 38332411 PMC: 10973088. DOI: 10.1007/s40256-023-00625-1.

Association of Single-Nucleotide Polymorphisms Rs2779249 (chr17:26128581 C>A) and Rs rs2297518 (chr17: chr17:27769571 G>A) of the Gene with Tension-Type Headache and Arterial Hypertension Overlap Syndrome in Eastern Siberia.

Alyabyeva P, Petrova M, Dmitrenko D, Garganeeva N, Chumakova G, Al-Zamil M Genes (Basel). 2023; 14(2).

PMID: 36833440 PMC: 9957272. DOI: 10.3390/genes14020513.

The Role of Single Nucleotide Variants of and Genes in the Development of the Phenotype of Migraine and Arterial Hypertension.

Moskaleva P, Shnayder N, Petrova M, Kaskaeva D, Gavrilyuk O, Radostev S Brain Sci. 2021; 11(6).

PMID: 34200123 PMC: 8228947. DOI: 10.3390/brainsci11060753.

The Role of Single-Nucleotide Variants of , and Genes in the Comorbidity of Arterial Hypertension and Tension-Type Headache.

Shnayder N, Petrova M, Moskaleva P, Shesternya P, Pozhilenkova E, Nasyrova R Molecules. 2021; 26(6).

PMID: 33809023 PMC: 8002043. DOI: 10.3390/molecules26061556.

Ankylosing spondylitis risk factors: a systematic literature review.

Hwang M, Ridley L, Reveille J Clin Rheumatol. 2021; 40(8):3079-3093.

PMID: 33754220 PMC: 9044547. DOI: 10.1007/s10067-021-05679-7.

References

Pauletto P, Rattazzi M . Inflammation and hypertension: the search for a link. Nephrol Dial Transplant. 2006; 21(4):850-3. DOI: 10.1093/ndt/gfl019. View

Huan T, Esko T, Peters M, Pilling L, Schramm K, Schurmann C . A meta-analysis of gene expression signatures of blood pressure and hypertension. PLoS Genet. 2015; 11(3):e1005035. PMC: 4365001. DOI: 10.1371/journal.pgen.1005035. View

Amrani-Midoun A, Kiando S, Treard C, Jeunemaitre X, Bouatia-Naji N . The relationship between MTHFR C677T gene polymorphism and essential hypertension in a sample of an Algerian population of Oran city. Int J Cardiol. 2016; 225:408-411. DOI: 10.1016/j.ijcard.2016.10.027. View

Kearney P, Whelton M, Reynolds K, Muntner P, Whelton P, He J . Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365(9455):217-23. DOI: 10.1016/S0140-6736(05)17741-1. View

Rafiq S, Anand S, Roberts R . Genome-wide association studies of hypertension: have they been fruitful?. J Cardiovasc Transl Res. 2010; 3(3):189-96. DOI: 10.1007/s12265-010-9183-9. View

Kumar U, Chen J, Sapoznikhov V, Canteros G, White B, Sidhu A . Overexpression of inducible nitric oxide synthase in the kidney of the spontaneously hypertensive rat. Clin Exp Hypertens. 2005; 27(1):17-31. DOI: 10.1081/ceh-200044249. View

Umar S, van der Laarse A . Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem. 2009; 333(1-2):191-201. DOI: 10.1007/s11010-009-0219-x. View

Mayer B, Hemmens B . Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci. 1998; 22(12):477-81. DOI: 10.1016/s0968-0004(97)01147-x. View

STOCLET J, Muller B, GYORGY K, Andriantsiothaina R, Kleschyov A . The inducible nitric oxide synthase in vascular and cardiac tissue. Eur J Pharmacol. 1999; 375(1-3):139-55. DOI: 10.1016/s0014-2999(99)00221-6. View

10.

Smith C, Santhanam L, Bruning R, Stanhewicz A, Berkowitz D, Holowatz L . Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension. 2011; 58(5):935-42. PMC: 3209704. DOI: 10.1161/HYPERTENSIONAHA.111.178129. View

11.

Rodriguez-Iturbe B, Zhan C, Quiroz Y, Sindhu R, Vaziri N . Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension. 2003; 41(2):341-6. DOI: 10.1161/01.hyp.0000052833.20759.64. View

12.

Escames G, Khaldy H, Leon J, Gonzalez L, Acuna-Castroviejo D . Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine. J Hypertens. 2004; 22(3):629-35. DOI: 10.1097/00004872-200403000-00027. View

13.

Nikkari S, Maatta K, Kunnas T . Functional Inducible Nitric Oxide Synthase Gene Variants Associate With Hypertension: A Case-Control Study in a Finnish Population-The TAMRISK Study. Medicine (Baltimore). 2015; 94(46):e1958. PMC: 4652812. DOI: 10.1097/MD.0000000000001958. View

14.

Wang S, Davis S, Cerhan J, Hartge P, Severson R, Cozen W . Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. Carcinogenesis. 2006; 27(9):1828-34. DOI: 10.1093/carcin/bgl013. View

15.

Zhang X, Zhao H, Zhang J, Han D, Zheng Y, Guo X . Gene environment interaction of GALNT2 and APOE gene with hypertension in the Chinese Han Population. Biomed Mater Eng. 2015; 26 Suppl 1:S1977-83. DOI: 10.3233/BME-151501. View

16.

Castro M, Rizzi E, Rodrigues G, Ceron C, Bendhack L, Gerlach R . Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Radic Biol Med. 2009; 46(9):1298-307. DOI: 10.1016/j.freeradbiomed.2009.02.011. View

17.

Rutherford S, Johnson M, Curtain R, Griffiths L . Chromosome 17 and the inducible nitric oxide synthase gene in human essential hypertension. Hum Genet. 2001; 109(4):408-15. DOI: 10.1007/s004390100565. View

18.

Hayakawa H, Raij L . Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension. 1998; 31(1 Pt 2):266-70. DOI: 10.1161/01.hyp.31.1.266. View

19.

Kuhl S, Rosen H . Nitric oxide and septic shock. From bench to bedside. West J Med. 1998; 168(3):176-81. PMC: 1304857. View

20.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903-13. DOI: 10.1016/s0140-6736(02)11911-8. View